Deborah Andrews

Interim Co-CEO and CFO

CEO CFO Chief Accounting Officer Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Staar Surgical Co (STAA)	Chief Financial Officer	$810,173	—	$1,400,016	—	$367,538	$4,684	$2,582,411
2019	Staar Surgical Co (STAA)	Vice President, Chief Financial Officer	$351,299	$167,112	—	$308,780	—	$27,021	$854,212
2018	Staar Surgical Co (STAA)	Vice President, Chief Financial Officer	$341,443	$251,797	—	$206,986	—	$23,254	$823,480
2017	Staar Surgical Co (STAA)	Vice President, Chief Financial Officer	$305,315	$96,778	$213,875	$226,073	—	$23,014	$865,056

Executive changes

Appointed Interim Co-Chief Executive Officer at Staar Surgical Co (STAA)
2026-02-01
Appointed Chief Financial Officer at Staar Surgical Co (STAA)
2025-06-25
Appointed principal accounting officer at Staar Surgical Co (STAA)
2025-03-17
Appointed Interim Chief Financial Officer at Staar Surgical Co (STAA)
2025-03-17
Appointed Director at Lineage Cell Therapeutics, Inc. (LCTX)
2023-09-06

Earnings-call appearances

Staar Surgical Co Q4 FY2026 Earnings Call
Staar Surgical Co (STAA)

2026-03-03
Staar Surgical Co Q4 FY2025 Earnings Call
Staar Surgical Co (STAA)

2025-02-11
Staar Surgical Co Q1 FY2025 Earnings Call
Staar Surgical Co (STAA)

2024-05-07
Staar Surgical Co Q1 FY2020 Earnings Call
Staar Surgical Co (STAA)

2019-05-01